title: Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis.
authors.forename: Hélène
authors.initials: H
authors.lastname: Vallet
authors.forename: Ronan
authors.initials: R
authors.lastname: Houitte
authors.forename: Alexandre
authors.initials: A
authors.lastname: Azria
authors.forename: Xavier
authors.initials: X
authors.lastname: Mariette
mesh_terms: D000361:Agammaglobulinemia / Q000097:blood / Q000209:etiology*; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003092:Colitis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D016133:Polymerase Chain Reaction; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D000069283:Rituximab